Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -5,270 | -1,409 | N/A |
| Depreciation Amortization | 10 | 18 | N/A |
| Other Working Capital | -1,542 | 73 | N/A |
| Other Operating Activity | 174 | 90 | 0 |
| Operating Cash Flow | $-6,628 | $-1,228 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -17 | -6 | N/A |
| Investing Cash Flow | $-17 | $-6 | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | 300 | N/A |
| Common Stock Issued | 18 | N/A | N/A |
| Other Financing Activity | 8,030 | 8,582 | 0 |
| Financing Cash Flow | $8,048 | $8,882 | $N/A |
| Beginning Cash Position | 8,634 | 986 | N/A |
| End Cash Position | 10,037 | 8,634 | N/A |
| Net Cash Flow | $1,403 | $7,648 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -6,628 | -1,228 | N/A |
| Capital Expenditure | -17 | -6 | N/A |
| Free Cash Flow | -6,645 | -1,234 | 0 |